NPI registry status
Active
2026 NPPES data Nephrology Physician NPI 1659467769 M.D.
Verify on CMS → Mark Adaimy, M.D.
Nephrology Physician in Las Vegas, Nevada.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,806 in Nephrology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 246 beneficiaries · Nephrology Physician avg: 2K
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mark Adaimy, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 1,060 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 1K
- Part D claims, 2024
- 89%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mark Adaimy, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1659467769), first enumerated 10/05/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,060 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1659467769 · Nephrology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-NEUTRAL · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1659467769
- ENUM-LEGACY 2006
- TAX-MID 11K Nephrology Physician
- MIPS-NEUTRAL 75/100
- RX-MID 1,060
- BOOK-THIN 99 in Nevada
- PHOTO-ENUM Charles Hunter · 2006
Mark Adaimy, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,060 ≥ 75th percentile 75% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Mark Adaimy, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Adaimy, M.D.?
CMS neutral score, not measuredPrimary specialty
Nephrology Physician
Medicare Part D claims
1,060 30% vs specialty avg
MIPS final score
75/100
Specialty distribution in Nevada
How Nephrology Physician compares to other specialties among Nevada providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1659467769 |
|---|---|
| Specialty | Nephrology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 10/05/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Individual
Hospital and facility affiliations
Facilities where Mark Adaimy, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Qazi Makhija And Barney LLP
Las Vegas, NV
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
Mark Adaimy, M.D. - brand share 11.0%
Nephrology Physician average
11% brand-name claims vs 89% generic, on 1,060 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,060
Total Claims
$81K
Total Drug Cost
246
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,322.033
- Total Day Supply
- 68,175
- Brand vs Generic
- 11% brand / 89% generic
- Brand Drug Cost
- $68K
- Generic Drug Cost
- $13K
- Antibiotic Claims
- 47
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 2.22
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 27, 65-74: 102, 75-84: 90, 85+: 27
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mark Adaimy, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Furosemide
Furosemide
143 claims
- Lisinopril
Lisinopril
85 claims
- Hydrochlorothiazide
Hydrochlorothiazide
70 claims
- Calcitriol
Calcitriol
64 claims
- Amlodipine Besylate 52
Amlodipine Besylate
52 claims
- Hydralazine Hcl 40
Hydralazine Hcl
40 claims
- Tamsulosin Hcl 40
Tamsulosin Hcl
40 claims
- Allopurinol 39
Allopurinol
39 claims
| Drug | Claims |
|---|---|
| Furosemide | 143 |
| Lisinopril | 85 |
| Hydrochlorothiazide | 70 |
| Calcitriol | 64 |
| Amlodipine Besylate | 52 |
| Hydralazine Hcl | 40 |
| Tamsulosin Hcl | 40 |
| Allopurinol | 39 |
| Losartan Potassium | 34 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 30 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nephrology Physician Overview
How Mark Adaimy, M.D. fits within the Nephrology Physician landscape nationally.
10,806
Nephrology Physician Providers in US
55
States with Nephrology Physician
1,511
Avg Claims per Provider
Mark Adaimy, M.D.'s 1,060 claims are below the specialty average of 1,511.
Nationwide Nephrology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Adaimy, both outside Nevada so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Nephrology Physician Providers in Nevada
Other clinicians with the same primary specialty enrolled in Nevada, drawn from the same CMS NPPES roster as Adaimy.
One of 99 Nephrology Physician providers enrolled in Nevada, 5 are shown here.
Ayoola Adekile
Las Vegas, NV
Dr. Abdallah Alali
MD
Las Vegas, NV
Dr. Milen Amde
M.D.
North Las Vegas, NV
Dr. Marina Antar-Shultz
D.O.
North Las Vegas, NV
Dr. Narisorn Atsava-Svate
MD
Reno, NV
Compare Nephrology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mark Adaimy, M.D.'s specialty? ▼
Mark Adaimy, M.D. specializes in Nephrology Physician and practices in Las Vegas, Nevada. Credentials: M.D..
How much does Mark Adaimy, M.D. prescribe under Medicare Part D? ▼
In 2024, Mark Adaimy, M.D. wrote 1,060 Medicare Part D claims totaling $81K in drug costs for 246 beneficiaries.
What is Mark Adaimy, M.D.'s Medicare quality score? ▼
Mark Adaimy, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mark Adaimy, M.D. located? ▼
Mark Adaimy, M.D. is located at 2820 W CHARLESTON BLVD STE 33, Las Vegas, NV, 89102. Phone: (702) 880-1558.
What is Mark Adaimy, M.D.'s NPI number? ▼
Mark Adaimy, M.D.'s National Provider Identifier (NPI) is 1659467769, issued on 10/05/2006.
Does Mark Adaimy, M.D. prescribe more brand-name or generic drugs? ▼
Mark Adaimy, M.D.'s prescribing is 11% brand-name and 89% generic drugs by claim count, with $68K in brand drug costs.
How many Nephrology Physician providers are there in the US? ▼
There are 10,806 Nephrology Physician providers across 55 states in the US. The average Nephrology Physician provider writes 1,511 Medicare Part D claims per year.
What drugs does Mark Adaimy, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Mark Adaimy, M.D.'s most frequently prescribed drugs include Furosemide, Lisinopril, Hydrochlorothiazide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Adaimy, M.D. accept Medicare? ▼
Mark Adaimy, M.D. appears in CMS Medicare data with 1,060 Part D claims and 246 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Adaimy, M.D.'s credentials? ▼
Mark Adaimy, M.D.'s NPI is 1659467769 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.